Head and neck cancers (HNCs) are the most prevalent and aggressive type of cancers. Genetic, epigenetic, environmental and viral risk-factors are associated with HNC carcinogenesis. Persistent infection of oncogenic human papillomaviruses (HR-HPVs) represent distinct biological, molecular and epigenetic entities in HNCs. There are three main epigenetic mechanisms that regulate transcription, these are DNA methylation, histone modifications and alteration in non-coding RNA networks, which can dissected to identify innovative and accurate epigenetic biomarkers for diagnosis and prognosis of HNC patients. Due to the lacunae of accurate distinctive biomarkers for the definite diagnosis of HNC, the identification of predictive epigenetic markers is necessary that might modify or increase HNC patient's survival. In this mini review, we briefly summarize the current knowledge of different epigenetic biomarkers in HNC.
Introduction
Head and neck cancers (HNCs) are the 6 th most common and heterogenous group of malignancies with about 780,000 new cases being diagnosed every year and more than 350,000 deaths reported annually [1] .
Head and neck carcinogenesis is mainly caused by chronic use of tobacco products, excessive alcohol intake and persistent infection with oncogenic human papillomaviruses (HR-HPVs). HPV-positive HNCs represent distinct biological, molecular entities in comparison to the HPV-negative and tobacco induced
HNCs. HR-HPV infection significantly effect HNC prognosis. The HPV infected HNC patients are mainly non-tobacco smoking, younger age population with better prognosis than those with HPV-negative HNC patients [2] [3] [4] [5] [6] . These strong evidences establish the distinct molecular and clinical role of HPV as a unique viral biomarker for HNC diagnosis and prognosis. These distinct entities can be due to epimutations inspiring further investigation on molecular and epigenetic modifications to modify HNC patient's outcome.
It seems that HNC is as much a disease of misdirected epigenetic factors as that of genetic factors, which has emerged into one of the "hallmarks of cancers". Various scientific studies have suggested that epigenetic alterations such as DNA methylation and the post translational modifications of histone proteins and/ or mis-expression of non-coding RNAs (ncRNAs), are frequently associated with initiation, progression, differentiation and drug resistance in HNCs [7] .
Therefore, these epigenetic markers are emerging as important and reliable tools for early diagnosis and prognosis of HNC. In addition, dysregulation in any of these 3 distinct and mutually reinforcing epigenetic mechanisms lead to mis-regulation of gene expression, resulting in the development of HNCs [7] [8] [9] . Epigenetic alterations causing aberrant transcriptional activity, provide selective advantage to the tumor through the silencing of tumor suppressor genes or activation of oncogenes and/or mutation effecting DNA repair genes.
Epigenetic alterations are also involved in cellular plasticity during cancer progression, and further contribute to formation of cancer stem-like cells or cancer stem cells (CSCs) [10, 11] . In this mini review, we explore different epigenetic mechanisms that are known to be altered during HNC carcinogenesis.
Methylation Specific Biomarkers

DNA Methylation
DNA methylation is the best studied epigenetic mechanism in HNCs. Alterations in epigenetic mechanisms controlling DNA methylation lead to changes in genome-wide methylation patterns as well as promoter-specific and/or CpG island specific DNA methylation which play a critical role in HNC growth and development [12] . 
Epigenetic Modifiers as Diagnostic Markers in HNC:
Writers (Histone Modifiers)
The structure of chromatin is dynamic and its fundamental unit is the nucleosome, which consists of Over-expression of Polycomb complex member, enhancer of zeste homolog 2 (EZH2) in tongue cancer, correlates with reduced overall survival and was found to be of great prognostic importance [20] . In another study, SUZ12 overexpression in HNCs correlated with cervical node metastasis along with reduced survival. It was further shown that the knockdown of SUZ12
inhibited cell proliferation and migration [21] . In an independent study, mutations and copy number variations (CNVs) in MLL1, MLL2, MLL3, KDM6A and KDM6B were found to be a contributing factor in HNC progression [22] . Number of missense, nonsense and frameshift mutations in MLL2 and EZH2 are associated with HNCs [23] . Increased expression of histone deacetylase-2 (HDAC-2) associated with metastasis along with poor survival and further, served as a good prognostic marker for HNC patients [24] . These studies 
